Professional Documents
Culture Documents
ENDO O7
June 2 – 5
REGISTER EARLY
AND SAVE 20% ON
ENDO 07 REGISTRATION.
covering the breadth and scope that only the world's largest gathering of endocrinologists
can provide. The 2007 scientific program, presented by over 350 speakers, includes
and professional development opportunities than ever before. All of this in Toronto,
REGISTER NOW.
3
Endo2007_KCC TEXT 2/19/07 10:05 AM Page 4
È\ää È\Îä Ç\ää Ç\Îä n\ää n\Îä \ää \Îä £ä\ää £ä\Îä ££\ää ££\Îä £Ó\ää £Ó\Îä £\ää
* * *
,9Ê1
Ê£
iÜÃÊEÊ-ÌÕ`iÌÃÊ>ÞÊn\ääÊÈ\ääÊ*
-Ê-Þ«Ã>ÊÈ\ään\ääÊ
LÊ>ÀÊÇ\ÎäÊÈ\ÎäÊ*
*ÀiÃ`iÌ>Ê "ÕÌv
-Þ«Ã>Ê *ÃÌiÀÃ Ì
i ÝÊ Ü
*i>ÀÞÊÊ ££\ääÊ£Ó\ääÊ*
n\ää\£xÊ \Î䣣\ääÊ £Ó\£x£\ääÊ* ,
-/1,9Ê1
ÊÓ
£\
/*½Ã iÜ
££\£xÊ /iV
}ÞÊ
£Ó\ääÊ* £Ó\£x£\ääÊ*
iL>Ìi º9i>ÀÊ»
££\£xÊ 1«`>ÌiÊ
£Ó\£xÊ* £Ó\Îä£\£xÊ*
/*½ÃÊ
£Ó\Îä£\£xÊ*
3#)%.4)&)# 02/'2!-
!4
!
',!.#%
-Ê-Þ«Ã>ÊÈ\ään\ääÊ
`VÀiÊ ÕÀÃiÃÊ-Þ«ÃÕÊÇ\ääÊx\ääÊ*
LÊ>ÀÊÇ\ÎäÊÈ\ÎäÊ*
"ÕÌv
*i>ÀÞÊÊ -Þ«Ã>Ê *ÃÌiÀÃ Ì
i ÝÊ
n\ää\£xÊ \Î䣣\ääÊ ££\ääÊ£Ó\ääÊ*
-1 9Ê1
ÊÎ
£Ó\£x£\ääÊ*
iL>Ìi iÜ
/*½Ã Ü
n\Îä\£xÊ ££\£xÊ /iV
}ÞÊ
£Ó\£xÊ* £Ó\£x£\ääÊ* ,
£\
/
-Ê
V> /*½ÃÊÊ
££\£x£Ó\ääÊ*Ê /*½ÃÊ
Õ`ii £Ó\£x£\ääÊ*
n\Îä\£xÊ Ài«i>ÌÊn\ÎäÊÊ
ÃiÃî
>ÀÊ/Ê->ÜÊ
iVÌÕÀiÊÊ
£Ó\Îä£\£xÊ*
-Ê-Þ«Ã>ÊÈ\ään\ääÊ
LÊ>ÀÊÇ\ÎäÊÈ\ÎäÊ*
"ÕÌv
*i>ÀÞÊÊ -Þ«Ã>Ê *ÃÌiÀÃ Ì
i ÝÊ
n\ää\£xÊ \Î䣣\ääÊ ££\ääÊ£Ó\ääÊ* £Ó\£x£\ääÊ*
" 9Ê1
Ê{
iL>Ìi iÜ
/*½Ã Ü
n\Îä\£xÊ ££\£xÊ /iV
}ÞÊ
£Ó\£xÊ* £Ó\£x£\ääÊ* ,
£\
/
-Ê
V> /*½ÃÊÊ
££\£x£Ó\ääÊ*Ê /*½ÃÊ
Õ`ii £Ó\£x£\ääÊ*
n\Îä\£xÊ Ài«i>ÌÊn\ÎäÊÊ
ÃiÃî
º9i>ÀÊ»ÊÊ
1«`>ÌiÊ
£Ó\Îä£\£xÊ*
-Ê-Þ«Ã>ÊÈ\ään\ääÊ
*i>ÀÞÊÊ -Þ«Ã>Ê *ÃÌiÀà /*½ÃÊ
n\ää\£xÊ \Î䣣\ääÊ ££\ää£Ó\ääÊ* £Ó\£x£\ääÊ*
iL>Ìi
/*½Ã º9i>ÀÊ»ÊÊ Ü
/1
-9Ê1
Êx
/
-Ê
V> /*½ÃÊÊ
Õ`ii ££\£x£Ó\ääÊ*Ê
n\Îä\£xÊ Ài«i>ÌÊn\ÎäÊÊ
ÃiÃî
ä £\Îä Ó\ää Ó\Îä Î\ää Î\Îä {\ää {\Îä x\ää x\Îä È\ää È\Îä Ç\ää Ç\Îä n\ää n\Îä \ää \Îä
* * * * * * * * * * * * * * * * *
/
ÞÀ`Ê-}À>«
ÞÊ7ÀÃ
«Ê££\ÎäÊÈ\ÎäÊ*
LÊ>ÀÊ£\ääÇ\ääÊ*
ÌÕ}ÊÕVÃiÊÌÀ}Ê7ÀÃ
«Ê£\ÎäÈ\ääÊ*
Ê-
*Êx\ää\ääÊ*
-ÊÈ\Îä\ÎäÊ*
ÛiÀÃ>ÌÃÊ /*½Ã
ÜÌ
Ê >ÃVÊ *ÃÌiÀà -Þ«Ã>ÊÎ\{xx\£xÊ* x\ÎäÈ\£xÊ*
,iÃi>ÀV
iÀà Ó\ÎäÎ\ÎäÊ* Ài«i>ÌÊ£Ó\£xÊ*Ê
£\£xÓ\ääÊ* ÃiÃî
/*½Ã
"À>ÃÊÊ Ó\{xÎ\ÎäÊ* *i>ÀÞ
£\£xÓ\ÎäÊ* Ài«i>ÌÊ££\£xÊÊ x\ÎäÈ\ÎäÊ*
ÃiÃî
-Ê-Þ«Ã>ÊÈ\Îä\ÎäÊ*
*
*
/*½Ã
"À>ÃÊÊ *ÃÌiÀà -Þ«Ã>ÊÎ\{xx\£xÊ* x\ÎäÈ\£xÊ*
£\£xÓ\ÎäÊ* Ó\ÎäÎ\ÎäÊ* Ài«i>ÌÊ£Ó\£xÊ*Ê
ÃiÃî
ÛiÀÃ>ÌÃÊ
ÜÌ
Ê >ÃVÊ *i>ÀÞ
,iÃi>ÀV
iÀà x\ÎäÈ\ÎäÊ*
£\£xÓ\ääÊ*
-Ê-Þ«Ã>ÊÈ\Îä\ÎäÊ*
ÜÊ
*
/*½Ã
"À>ÃÊÊ *ÃÌiÀà -Þ«Ã>ÊÎ\{xx\£xÊ* x\ÎäÈ\£xÊ*
£\£xÓ\ÎäÊ* Ó\ÎäÎ\ÎäÊ* Ài«i>ÌÊ£Ó\£xÊ*Ê
ÃiÃî
ÛiÀÃ>ÌÃÊ
ÜÌ
Ê >ÃVÊ *i>ÀÞ
,iÃi>ÀV
iÀà x\ÎäÈ\ÎäÊ*
£\£xÓ\ääÊ*
-Ê-Þ«Ã>ÊÈ\Îä\ÎäÊ*
*
/*½Ã
"À>ÃÊÊ *ÃÌiÀà -Þ«Ã>ÊÎ\{xx\£xÊ* x\ÎäÈ\£xÊ*
£\£xÓ\ÎäÊ* Ó\ÎäÎ\ÎäÊ* Ài«i>ÌÊ£Ó\£xÊ*Ê
ÃiÃî
ÛiÀÃ>ÌÃÊ
ÊÜÌ
Ê >ÃVÊ *i>ÀÞ
,iÃi>ÀV
iÀà x\ÎäÈ\ÎäÊ*
* £\£xÓ\ääÊ*
Ã}Ê,iVi«ÌÊÈ\Îän\ääÊ*
Endo2007_KCC TEXT 2/23/07 12:38 PM Page 6
HIGHLIGHTS
Plenary Lectures 5:3 0 – 6:3 0 P M
Scientific Program
B C T E
Basic Clinical Translational Ethics
Endo2007_KCC TEXT 2/16/07 1:57 PM Page 7
HIGHLIGHTS
Sunday, June 3 New Perspectives in Endometriosis
Scientific Program
8:00 – 9:15 A M Linda C Giudice, MD, PhD, Univ of California-San Francisco
Advances in the Understanding of the Genetic Basis of Endometriosis is a common gynecologic disorder
Bone & Mineral Disorders associated with pelvic pain, infertility, and
Rajesh V Thakker, MD, Univ of Oxford (UK) increased risk of ovarian cancer. Diagnosis may
be delayed by years, and medical and surgical
Disorders of bone and calcium homeostasis,
therapies are less than satisfactory in most
which include osteoporosis and kidney stones,
women. Recent advances demonstrate that there
are common. The parathyroid glands play a
is a genetic component to endometriosis and
central role in these homeostatic pathways and
that endometriosis lesions make estrogen and
dysfunction of these glands, which may lead to
are resistant to progesterone, complicating the therapeutic paradigm,
hyper- or hypo-calcemia, is often associated
but also providing opportunities for innovation. This plenary
with genetic abnormalities. Investigation of
lecture will focus on current approaches to diagnosis and treatment
these genetic abnormalities has identified novel
of this disorder and how recent advances in molecular medicine
receptors, channels, and signaling pathways. Translation of these
are leading to novel diagnostics and therapeutics.
advances to the clinical setting has facilitated the diagnosis and
treatments of bone and mineral disorders. These advances and the
manner in which they have increased our understanding of the Monday, June 4
underlying molecular mechanisms will be reviewed. 8:00 – 9:15 A M
Regulation of Beta-Cell Mass in Humans: A Potential
Roy O Greep Award Lecture Therapeutic Target in Type 1 & 2 Diabetes?
Pituitary Development & Disease: Roles of Transcription Peter C Butler, MD, Univ of California-Los Angeles
Factors & Signaling Pathways Both type 1 and 2 diabetes are characterized by
Sally A Camper, PhD, Univ of Michigan deficits in beta-cell mass. The likely underlying
Pituitary hormone deficiency and pituitary mechanisms leading to these deficits will be
adenomas are common problems. Studies in discussed, including potential increased beta-cell
genetically engineered and mutant mice have loss and/or decreased beta-cell formation.
advanced understanding of the mechanisms Replacement of beta-cell mass by pancreas
underlying these disease processes. In most transplantation has been shown to reverse
cases, genes discovered in the mouse have metabolic defects in both type 1 and 2 diabetes.
quickly led to the discovery of lesions in human Organ donor pancreases are limited in supply, and this strategy
patients and have revealed the genetic requires long-term immunosuppression. What are the opportunities
hierarchy of control of pituitary cell specification and growth. for beta-cell regeneration in humans with type 1 and 2 diabetes?
What obstacles must be overcome to meet these objectives? These
questions will be addressed with the state-of-the-art information
5:3 0 – 6:3 0 P M at the time of presentation.
Tissue-Engineered Follicles
Teresa K Woodruff, PhD, Northwestern Univ
Edwin B Astwood Award Lecture
Few options currently exist for young women Lipid Metabolism & Diabetes Research
who face a life-preserving but fertility-threatening Lawrence C Chan, DSc, MBBS, Baylor Coll of Med
chemo- or radiation therapy for cancer.
Emergency in vitro fertilization may be an option I will discuss areas of lipid metabolism and
for those who can delay cancer-directed treatment diabetes research that have produced new concepts
and have a partner or sperm bank material for and paradigms that are applicable to broad areas
the generation of embryos. Ovarian tissue of cell biology and medicine. The first area deals
cryopreservation and autotransplantation is an with the elucidation of the structure and
option to restore fertility; however, it may increase the risk of metabolism of apoB and the soluble
reintroduction of hematologic or disseminated neoplastic cells. apolipoproteins, which led to new concepts
Methods to grow immature follicles in vitro eliminate the potential and pathways years ago, but whose relevance is
reintroduction of nascent cancer cells, provide autonomous genetic increasingly applicable, not only to lipid metabolism, but also to
material for women wishing to begin their own family, and eliminate other biomedical disciplines. Next, I will review how lipid droplet
the need to cryopreserve embryos. New 3-D culture systems simulate proteins regulate lipid homeostasis and the role of bone
physiological conditions using alginate hydrogels to mimic the marrow-derived cells in chronic diabetic complications. Finally, I
ovarian environment. I will provide an update on the progress in will discuss recent research on diabetes gene therapy, which may
understanding ovarian follicle growth and oocyte maturation lead to a new treatment, but which also changes our thinking on how
in vitro and the birth of healthy fertile mice from follicle cultures. transcription factors regulate gene expression and cell differentiation.
B C T E
7
Basic Clinical Translational Ethics
Endo2007_KCC TEXT 2/16/07 1:58 PM Page 8
HIGHLIGHTS
Plenary Lectures Continued Maternal Programming of Neuroendocrine Systems
Scientific Program
HIGHLIGHTS
Out-of-the-Box Workshops Clark T Sawin Memorial Lecture new
Scientific Program
The Out-of-the-Box Workshops invite (Supported by Novo Nordisk Inc.)
participants to step outside of their In the First Annual Clark T Sawin Memorial History of
professional roles and examine how the Endocrinology Lecture, Professor Bliss, author of the first biography
field of endocrinology touches the larger of Harvey Cushing to appear in five decades, will discuss some
world around us. These presentations unique perspectives on Harvey Cushing and the formative years
are designed to highlight issues of of endocrinology and The Endocrine Society. Following his
critical importance at the intersection presentation, Professor Bliss will be available for book signings of
of science, medicine, and public policy. his biographies on Cushing and Osler and his new edition of
“The Discovery of Insulin.”
Saturday, June 2
12:15 – 1:00 P M Sunday, June 3
Public Policy & Obesity E 12:3 0 – 1:15 P M
Michelle Mello, Harvard Sch of Public Hlth Harvey Cushing & the Early Years of “Endo-Criminology”
Michael Bliss, Univ of Toronto
There has been a lot of effort, particularly at the state government
level, to try to use public policy to prevent obesity, with a lot of
those efforts focusing on children and youth in the public schools.
What is the appropriate role for the government in influencing Clinical Practice Guideline Sessions new
an individual’s personal decisions about activity level and At the Clinical Practice Guideline Sessions, you will receive an
consumption? My position tends to be that there is a role for in-depth look at three of the Society’s guidelines. The Guideline
government in trying to lead people to healthier lifestyles, but Chairs will review the highlights, key recommendations, and
there is a significant backlash toward such moves. challenges, followed by a moderated 30-minute open discussion
with the Guideline Chair and Guideline Task Force members.
Sunday, June 3
12:15 – 1:00 P M Sunday, June 3
Endocrinology & Industry – Selling Sickness? E
8:3 0 – 9:15 A M
Pediatric Obesity
Alan Cassels, Univ of Victoria (Canada)
Moderator: Michael Freemark, Duke Univ Med Ctr
I think menopause stands as an example of a very successful Panel: Gil August (Chair), Ilene Fennoy, Francine R Kaufman,
medicalization of a normal passage of life. If you are female and Robert H Lustig, Janet H Silverstein, Phyllis W Speiser,
you live long enough, you will go through menopause, and if you Dennis M Styne
can produce products that treat this condition, you can be
guaranteed a large market. That whole term “hormone replacement” Monday, June 4
has really been developed and created largely by the 8:3 0 – 9:15 A M
manufacturers of estrogen replacement.
Thyroid Disease in Pregnancy
Moderator: Wilmar Wiersinga, Univ of Amsterdam
Monday, June 4 Panel: Les DeGroot (Chair), Marcos S Abalovich, Nobuyuki Amino,
12:15 – 1:00 P M Linda A Barbour, Rhoda H Cobin, Daniel Glinoer, Susan J Mandel,
The NIH Clinical & Translational Science Awards: Creating Alex Stagnaro-Green
Synergies between Basic & Clinical Investigators
Barbara Alving, Natl Ctr for Res Resources/NIH Tuesday, June 5
It is time to work together, time to be more than just the 8:3 0-9:15 A M
isolated researcher doing one-off clinical trials. It’s time to find Androgen Therapy in Women
out how we can synergize all of the tools and all of the intellect Moderator: Glenn D Braunstein, Cedars-Sinai Med Ctr/Univ of
that we have and make sure that we utilize all the discoveries that California-Los Angeles Sch of Med
have been made. Panel: Margaret E Wierman (Chair), Rosemary Basson, Susan R
Davis, Sundeep Khosla, Karen K Miller, William Rosner, Nanette
Santoro
B C T E
9
Basic Clinical Translational Ethics
Endo2007_KCC TEXT 2/26/07 3:27 PM Page 10
1:3 0 – 1:4 0 P M • Learn the similarities and differences in diagnostic and treatment
Introduction options for common and unusual problems in the discipline
Aaron Kowalski, Juvenile Diabetes Res Fdn & Jennifer Larsen, Target audience: Clinical Practitioners, Clinical Researchers,
Univ of Nebraska and Diplomates of the ABIM who hold time-limited (current or
lapsed) or non-time limited certificates in internal medicine
1:4 0 – 2:2 0 P M and/or subspecialties and added qualifications of internal medicine
Overview of Continuous Glucose Monitoring (CGM) are eligible to apply.
Steve Edelman, Univ of California-San Diego
Advance purchase of the module is encouraged; bring your module
2:2 0 – 2:5 0 P M to the session. The answer sheet needed for MOC is located in
Accuracy of CGM the purchased module. Diplomates may seek MOC only in
William Clarke, Univ of Virginia disciplines in which they have been certified. The session fee is
separate from registration fees. For advance purchase of the
2:5 0 – 4:00 P M module, or for additional information about the MOC program,
Clinical Use of Continuous Glucose Monitoring visit www.abim.org or call 800.441.2246, extension 3593.
Irl Hirsch, Univ of Washington
Satish Garg, Barbara Davis, Univ of Colorado
Francine Kaufman, Univ of Southern California
William Tamborlane, Yale Univ
4:00 – 4:15 P M
Break
4:15 – 4:4 5 P M
Incorporating CGM in a Health Care Practice
Dan Mendelson, Avalere Hlth
Scientific Program
new Basic Fellows & Students Track
8:00 A M – 6:00 P M 9:3 0 A M – 6:00 P M
(Supported by Abbott Laboratories, AstraZeneca, Berlex Laboratories, The Rewards of a Career in Science Transcription & Novel
Novo Nordisk Inc., Pfizer, Inc. & Sanofi-Aventis) Mechanisms of Gene Regulation
This workshop provides valuable trainee education in both basic Transcription in Live Cells
and clinical tracks. The Basic Track will include leading
researchers presenting exciting new technologies, personal Dispelling the Myths: Research experiences in Academia,
experiences, tips on choosing a postdoc, job opportunities, and Industry, & Government
much more. The Clinical Track will include thought leaders Break-Out Sessions:
presenting perspectives on the diagnosis and treatment of Basic Science Outside the US: Is the Grass Greener?
endocrine disorders, advice on setting up a private practice, and Networking Mentoring & Self-promotion Basics for
strategies for achieving a healthy balance between career and Basic Scientists
personal life. Selected applicants will receive travel reimbursement, Finding the Right Flavor of Job for You
one night of housing, and complimentary registration to ENDO 07.
For application details, visit www.endo-society.org/endo/development. Finding the Right Postdoc
Careers in Industry
8:00 – 8:2 0 A M Career/Life Balance Panel Discussion
Welcome & Overview
Leonard Wartofsky, President, The Endocrine Society
Fellow & Student Reception
8:2 0 – 8:3 0 A M 6:3 0 – 7:3 0 P M
Finding Your Niche at ENDO All fellows and students attending ENDO 07 are invited to this
The ENDO 07 Program Chairs popular event. Catch up with colleagues and friends, enjoy light
refreshments, and join The Endocrine Society in honoring all
8:3 0 – 9:3 0 A M ENDO travel grant recipients. Please indicate your interest in
Plenary Lectures attending this reception by marking the appropriate box on the
ENDO 07 Registration Form (see page 45).
Clinical Fellows Track Contact: Danielle Jordan at djordan@endo-society.org
9:3 0 A M – 6:00 P M or 301.951.2616.
Insights into Thyroid Cancer
Thyroid Disorders & Pregnancy
Bone & Mineral Update
Break-Out Sessions:
Male Reproduction
PCOS
Pituitary Disorders
Diabetes & Lipids
Osteoporosis
Obesity Management
Endocrine Hypertension
Update in Diabetes Management
Pediatric Endocrinology
Obesity Pathophysiology: Adipose Tissue as an Endocrine Organ
Pituitary
Private Practice
Career/Life Balance Panel Discussion
B C T E
11
Basic Clinical Translational Ethics
Endo2007_KCC TEXT 2/16/07 2:12 PM Page 12
Scientific Program
& Adult Pituitary B Lactation Didier Picard, Univ of Geneva
Chair: Sally Camper, Univ of Michigan Dionysia Theodosis, Univ de Bordeaux Acetylation of Nuclear Receptors
Med Sch (France) Richard Pestell, Kimmel Cancer Ctr
Developmental Signals during Pituitary Estrogen & Hippocampal Neural (Philadelphia, PA)
Organogenesis Plasticity
Jacques Drouin, Inst de Recherches Clin de Catherine Woolley, Northwestern Univ 3:4 5 – 5:15 P M
Montreal
Adiponectin, Obestatin & Ghrelin
The Pituitary Side Population: An Hormone Disruption & Early Origins Signaling Surprises B
Embryonic Compartment in the Adult of Disease B Chair: Gary Sweeney, York Univ (Canada)
Gland? Chair: Christine L Clarke, Westmead Inst Obestatin
Hugo Vankelecom, Katholieke Univ Leuven for Cancer Res (Australia) Aaron Hsueh, Stanford Univ Sch of Med
(Belgium) Fibroids & Early Development Adiponectin
Molecular Targets in Pituitary Tumors Cheryl Walker, Univ of Texas MD Anderson Lily Dong, Univ of Texas Hlth Sci Ctr-San
Anthony Heaney, Cedars-Sinai Med Ctr Cancer Ctr Antonio
Developmental Origin of PCOS: Is Ghrelin Receptor Mutations
Sunday, June 3 Maternal Hyperandrogenism the Culprit? Birgitte Holst, Univ of Copenhagen
9:3 0 – 11:00 A M Vasantha Padmanabhan, Univ of Michigan
Structural Determinants of Ligand- Growth Hormone in Aging T
Control of GnRH: The Role of Genetic
Studies in Expanding Our Dependent Specificity in the Chair: Barbara C Hansen, Univ of South
Understanding of Neuroendocrine Mineralocorticoid Receptor Florida-Tampa
Mechanisms T Paul M Foster, NIEHS/NIH Maintenance of Cognitive Function in
Chair: Kathleen Whitlock, Cornell Univ the Aging Brain by GH
Insulin, Calories & Longevity B
Lessons from GPR54 Mutations in William Sonntag, Wake Forest Univ Sch of
Chair: Joan Lakoski, Univ of Pittsburgh Sch
Idiopathic Hypogonadotropic Med
of Hlth Sci
Hypogonadism GH-Regulated Genes as Markers of Aging
Insulin/IGF Regulation of Drosophila Aging
Nicolas de Roux, Hosp Robert Debra (France) John Kopchick, Ohio Univ/Edison Biotech
Marc Tatar, Brown Univ
Novel Genes Causing Kallmann’s Inst
lnsulin, Caloric Restriction & Lifespan in
Syndrome GH & Lifespan in Mammals
Mice
Nelly Pitteloud, Massachusetts Gen Hosp Holly Brown-Borg, Univ of North Dakota
Kevin Flurkey, Jackson Lab
Analysis of Kallmann’s Syndrome through
Sirtuins & Beta Cells
the Prism of Structural Biology Life Cycle of the GnRH Neuron B
Shin Imai, Washington Univ Sch of Med
Moosa Mohammadi, New York Univ (Supported by Abbott Diagnostics)
Med Ctr Isoform-Specific Functions of T3 Chair: Ei Terasawa, Univ of Wisconsin
Receptors B Fetal Development of GnRH Neuronal
Growth Hormone Signaling B Chair: Ann Marie Zavacki, Brigham & Systems
(Supported by Novo Nordisk Inc.) Women’s Hosp Stuart Tobet, Colorado State Univ
Chair: Ilene Fennoy, Columbia Univ Role of TR Isoforms in Signaling Pathway Kisspeptin, GnRH & Puberty
Med Ctr during Intestine Development Robert Steiner, Univ of Washington
Complexity of GH Actions at the Jacques Samarut, Ecole Normale Superieure Neuroendocrine Regulation in Menopause
Growth Plate de Lyons (France) Naomi Rance, Univ of Arizona
Jeffrey Baron, NICHD/NIH Thyroid Hormone Receptor- (TR- )Plays
GH, Neuronal Stem Cells & SOCS-2 a Critical Role in Skeletal Development Normal & Oncogenic Roles of Activin,
Michael Waters, Univ of Queensland Inhibin & Other TGF Beta-Related
& the Establishment & Maintenance of
GH Signaling Overview Ligands B
Adult Bone
Christin Carter-Su, Univ of Michigan Chair: Alan Schneyer, Massachusetts
John D Bassett, Imperial Coll (UK)
Med Sch Gen Hosp
TR Isoform-Specific Functions in the Heart
Myostatin & Muscle Growth
Onno Bakker, Univ of Amsterdam
Hormonal Control of Neuroplasticity B Se-Jin Lee, Johns Hopkins Univ Sch of Med
(Netherlands)
Chair: Darrell Brann, Inst of Molec Med & BMP Actions on Cartilage & Bone
Genet (Augusta, GA) Karen M Lyons, Univ of California-Los
Regulatory Modifications of Nuclear
Androgen Modulation of Synaptic Receptors B Angeles David Geffen Sch of Med
Plasticity Chair: Susan Logan, New York Univ Activin/TGF-Beta Signaling & the
Neil MacLusky, Helen Hayes Hosp (West Sch of Med Control of Cellular
Haverstraw, NY) Sumoylation of Androgen Receptors Proliferation/Apoptosis
Jorma Palvimo, Univ of Kuopio (Finland) Jean-Jacques Lebrun, Royal Victoria
Hosp/McGill Univ (Canada)
B C T E
13
Basic Clinical Translational Ethics
Endo2007_KCC TEXT 2/16/07 2:13 PM Page 14
Scientific Program
miRNA & Pancreatic Beta-Cell Function Regulation of Gametogenesis by PIWI- Nuclear Receptor Coregulators B
Markus Stoffel, Rockefeller Univ Interacting RNA/Male Sterility by Miwi Chair: Karen Knudsen, Univ of Cincinnati
Nature’s Own Regulatory Genes Affecting Mutations Coll of Med
Metabolism: miRNA Speaker To Be Announced Roles of Protein-Protein Interactions &
Peter J Leedman, Western Australia Inst Protein Methylation in Nuclear Receptor
Med Res Nongenomic Actions of Steroid Coregulator Function
Hormones B Michael Stallcup, Univ of South
Tuesday, June 5 Chair: Teresita Bellido, Univ of Arkansas for Carolina/Norris Comp Cancer Ctr
9:3 0 – 11:00 A M Med Sci ART-27: A Novel Coactivator for the
Novel Functions of Thyroid Hormone Androgen Receptor
Advances in Thyroid Hormone
Receptors: Beyond Nucleus-Initiated Michael Garabedian, New York Univ
Metabolism B
Transcription Sch of Med
Chair: Valerie Galton, Dartmouth Med Sch
Sheue-Yann Cheng, NCI/NIH Steroid Receptors, Chaperones & the
Deiodinase Knockout Mouse Models
Src Signaling & Progesterone Receptor Development of the Female Reproductive
Donald St Germain, Dartmouth Med Sch
Action Tract
Regulation of Deiodinase by
Dean Edwards, Baylor Coll of Med Edwin Sanchez, Med Univ of Ohio
Ubiquitination
Estrogen Signaling in Vascular Cells
Antonio Bianco, Brigham & Women’s Hosp
Tommaso Simoncini, Univ of Pisa (Italy) Signal Transduction in the
Control of Deiodinase by Selenium
Gonadotrope B
Josef Koehrle, Inst Exp Endo/Charite
Novel Disorders of Water Metabolism: Chair: Ursula Kaiser, Brigham & Women’s
(Germany) There’s Something New in the Hosp/Harvard Med Sch
Water T GnRH Signaling Genomics in
Genetics of Adipocyte Substrate Chair: Chris Thompson, Beaumont Gonadotropes
Metabolism B
Hosp/Royal Coll of Surg in Ireland Med Sch Stuart Sealfon, Mt Sinai Sch of Med
Chair: Rexford Ahima, Univ of
Aquaporin-1 Full Contact Origami: Cellular Trafficking
Pennsylvania Sch of Med
Soren Nielsen, Aarhus Univ Hosp of the GnRH Receptor in Health & Disease
Triglyceride Synthesis & Insulin
(Denmark) P Michael Conn, Oregon Hlth & Sci Univ
Resistance
Syndrome of Inappropriate Antidiuresis Transcriptional Regulation of
Robert V Farese, Jr, J David Gladstone Inst
Stephen Gitelman, Univ of California-San Gonadotropin Genes
(San Francisco, CA)
Francisco Pamela Mellon, Univ of California-
Genetic Defects in Fat Metabolism
Vasopressin Antagonists San Diego
James Ntambi, Univ of Wisconsin-Madison
Florence Wong, Univ of Toronto
Fatty Acid Oxidation in the Periphery &
The Renin-Angiotensin-Aldosterone
Insulin Resistance in Humans
Melanie Gillingham, Oregon Hlth &
3:4 5 – 5:15 P M System T
Mechanisms of Ovarian Function B Chair: Morag Young, Prince Henry’s
Sci Univ
Chair: Raymond J Rodgers, Univ of Inst/Monash Med Ctr (Australia)
Adelaide Med Sch Structural Determinants of Ligand-
IGFs & Cancer T
Intrinsic Mechanisms of Ovarian Dependent Specificity in the
Chair: Terri Wood, New Jersey Med
Function Mineralocorticoid Receptor
Sch/Univ of Med & Dent of New Jersey
JoAnne S Richards, Baylor Coll of Med Peter Fuller, Prince Henry’s Inst/Monash
Inhibition of Oncogenic Actions of IGF-
Ovarian Development & Sex Reversal Med Ctr (Australia)
IR with PPP
Richard Behringer, Univ of Texas MD Interaction of Gonadal Steroids & the
Olle Larsson, Karolinska Inst (Sweden)
Anderson Cancer Ctr RAAS
IGF & IGFBP in Epithelial Tumors
Germ Cell Tumors in the Intersex Gonad Ellen Seely, Brigham & Women’s
Michael Pollack, Lady Davis Res Inst,
Leendert HJ Looijenga, Erasmus Med Ctr Hosp/Harvard Univ
McGill Univ (Canada)
(Netherlands) Mineralocorticoid Actions in Nonclassic
Estrogen, IGF-1 & Cancer
Target Tissues
Eva Surmacz, Temple Univ
Mitochondria in Metabolic Disease T Martin Wehling, Univ of Heidelberg-
Chair: Gerald Shulman, Yale Univ Sch of Mannheim
New Concepts in Male
Reproduction B Med/HHMI
Chair: Philippa T Saunders, Queen’s Med Mitochondrial Genetics & Metabolic
Res Inst (Scotland) Syndrome
Retinoid Signaling & Germ Cell Fate Douglas Wallace, Univ of California-Irvine
Peter Koopman, Univ of Queensland Insulin Regulation & Mitochondrial
The Spermatogonial Stem Cells Niche Metabolism
Paul Cooke, Univ of Illinois-Urbana Kitt F Petersen, Yale Univ Sch of Med
Improving Metabolism in Mitochondria
Ulrik Wisloff, Norwegian Univ Sci & Tech
B C T E
15
Basic Clinical Translational Ethics
Endo2007_KCC TEXT 2/16/07 2:14 PM Page 16
new
Incorporate a new technique in the research plan of your next Ask a thought leader about his or her personal experiences in
grant. The New Technology Lecture series provides endocrine science. Targeted specifically to graduate students, fellows, and
investigators with an opportunity to hear from thought leaders in junior faculty, these sessions are intended to be informal, 45-
new, emerging, or evolving fields of scientific discovery. See and minute discussions with leading endocrine investigators.
hear first-hand what an expert has to say about the power and
limitations of a new technology. These sessions will take place on Saturday, June 2 and Sunday,
June 3, or Monday, June 4 and Tuesday, June 5, 1:15 – 2:00 PM.
Check the ENDO Web site for updates on the dates and times
Saturday, June 2 of these sessions.
12:15 - 1:00 P M
Epigenetics Meets Endocrinology
Conversations about the HPA Axis
Shuk-mei Ho, Univ of Cincinnati
Mary Dallman, Univ of California-San Francisco
Sunday, June 3 Conversations with the Editor-in-Chief of Molecular
12:15 - 1:00 P M Endocrinology
Comparative Oncogenomics for Gene Discovery (Second- John A Cidlowski, NIEHS/NIH
Generation Microarrays) Conversations about Cell Signaling
Arul Chinnaiyan, Univ of Michigan Med Sch Anthony R Means, Duke Univ Med Ctr
Monday, June 4 Conversations about Prolactin & Growth Hormone
12:15 - 1:00 P M Paul A Kelly, Fac Med Necker (France)
Bioinformatics & Cancer: An Essential Alliance Conversations about Thyroid & Nuclear Hormone Action
Joaquin Dopazo, Centro de Investigacion Gregory A Brent, VA Greater LA Hlthcare
Principe Felipe (Spain)
Conversations about Diabetes
Derek LeRoith, Mt Sinai Sch of Med
Conversations about Calcium & Bone
Henry M (Hank) Kronenberg, Massachusetts Gen Hosp
Conversations about Nuclear Receptor Biology
Keith Yamamoto, Univ of California-San Francisco
Conversations on Steroidogenesis
Carole R Mendelson, Univ Texas SW Med Ctr-Dallas
Conversations with the Editor-in-Chief of Endocrinology
Jeffrey Pessin, State Univ of New York
Conservations about the HPG Axis & Neuroendocrinology
Robert Steiner, Univ of Washington
Scientific Program
Symposia Thyroid Autoimmunity & Pregnancy C
Chair: Rosalind Brown, Children’s Hosp
Hypopituitarism in Long-Term
Survivors of Childhood Cancer C
(Boston, MA) (Supported by Pfizer, Inc.)
Saturday, June 2 Thyroid Autoimmunity & Pregnancy Loss Chair: Charles Sklar, Memorial Sloan-
9:3 0 – 11:00 A M Alex Stagnaro-Green, Univ of Med & Dent Kettering Cancer Ctr
Central & Peripheral Actions of of New Jersey Who & How To Test for Hypopituitarism
Ghrelin T Fetal Microchimerism & Thyroid Helena Gleeson, Christie Hosp (UK)
Chair: Ezio Ghigo, Univ of Turin/Osped Autoimmunity Risks & Benefits of GH Therapy
Molinette (Italy) Klaus Badenhoop, Univ Hosp Frankfurt am Anders Juul, Rigshospitalet (Denmark)
Central & Peripheral Effects of Ghrelin: Main (Germany) Pituitary-Gonadal Function
Interaction with AMPK Maternal Thyroid Function & Outcome W Hamish Wallace, Royal Hosp for Sick
Marta Korbonits, St Bartholomew’s Hosp (UK) of Pregnancy Children (Scotland)
Regulation of GH Secretion John Lazarus, Cardiff Univ Sch of Med (UK)
Michael Thorner, Univ of Virginia Hlth Syst Mouse Models of Nuclear Receptor-
Gastrokinetic Effects Update on Bariatric Surgery C Related Diseases T
Theo Peeters, Katholieke Univ Leuven (Supported by Sanofi-Aventis) Chair: Kathleen Ann Mahon, Baylor Coll
(Belgium) Chair: Diva De Leon, Children’s Hosp of of Med
Philadelphia Oncogenic AR Mutation
CRH: 25 Years Later T Clinical Approaches to the Bariatric Wayne Tilley Univ of Adelaide/Hanson Inst
Chair: WylieVale, Salk Inst Surgical Patient Xenobiotic Receptors & Immune
CRH in Early-Life Stress & H-P-A Axis George Bray, Louisiana State Univ Dysfunction
Neuroplasticity Pennington Biomed Ctr Bruce Blumberg, Univ of California-Irvine
Tallie Baram, Univ of California-Irvine Bariatric Surgery: Eligibility & Methods Kennedy’s Disease: Mouse Models,
Physiological Functions of Urocortin 2 Bruce Wolfe, Oregon Hlth Sci Univ Molecular Mechanisms & Therapeutic
Alon Chen, Weizmann Inst of Sci (Israel) Metabolic Consequences of Bariatric Strategies
Urocortins in Cardiovascular Health & Surgery Andrew Lieberman, Univ of Michigan
Disease Karen Foster-Schubert, VA Puget Sound Med Sch
A Mark Richards, Univ of Otago (New Hlth Care Syst (Seattle, WA)
Zealand) Novel Genes in Thyroid Cancer T
What’s New in Turner’s Syndrome? C (Supported by Genzyme Corporation)
New Insights into Phosphate (Supported by Eli Lilly & Company) Chair: Ronald Koenig, Univ of Michigan
Regulation in Health & Disease T Chair: Josephine Kasa-Vubu, Univ of Med Ctr
Chair: Suzanne Jan De Beur, Johns Hopkins Michigan Hlth Sys MCIP-1 & Thyroid Cancer Metastases
Univ Sch of Med Genetic Basis of Anomalies Matthew Ringel, Ohio State Univ
Regulation of Phosphate Metabolism: Judith Ross, Jefferson Med Coll Role of microRNAs in Follicular Thyroid
Normal Physiology & Pathophysiology of (Philidelphia, PA) Carcinogenesis
Disease Controversies in Therapy Charis Eng, Cleveland Clin
Sherri-Ann Burnett, Massachusetts Gen Hosp Cheri Deal, St Justine Hosp (Canada) Pituitary Tumor Transforming Gene
Role of FGF23 & Other Phosphatonins in Morbidity & Mortality (PTTG) Promotes Thyroid Cancer
Disorders of Phosphate Metabolism Claus Gravholt, Aarhus Univ Hosp Progression
Anthony Portale, Univ of California-San (Denmark) Christopher McCabe, Univ of Birmingham
Francisco (UK)
Insights into the Regulation of Phosphate 3:4 5 – 5:15 P M
Metabolism Using Transgenic & Ovarian Failure C
Knockout Mice Disparities in Endocrine Health of
Chair: Corrine K Welt, Massachusetts Gen
Rajiv Kumar, Mayo Clin Minorities C
Hosp
Chair: James Gavin III, MicroIslet, Inc
MIS/AMH as a Marker of Ovarian
Polycystic Ovary Syndrome & (San Diego, CA)
Function
Infertility C Disparities in the Pathophysiology &
Axel P Themmen, Erasmus Med Ctr
Chair: Sabrina Gill, St Paul’s Hosp (Canada) Management of Hypertension: Focus on
(Netherlands)
Metformin/No Metformin: PPCOS African Americans
Autoimmune Mechanisms in Premature
Results Crystal Gadegbeku, Univ of
Ovarian Failure
Evan R Myers, Duke Univ Med Ctr Michigan/Simpson Mem Inst
Alberto Falorni, Univ of Perugia (Italy)
Use of Aromatase Inhibitors in PCOS Treatment of Obesity: Does Culture Matter?
The Fragile X Premutation & Premature
Robert F Casper, Toronto Ctr for Advanced Shiriki Kumanyika, Univ of Pennsylvania
Ovarian “Failure”
Sch of Med
Repro Tech (Canada) Lawrence M Nelson, NICHD/NIH
Health of Minority Children in the US in
Oocyte Development in Women with
2007 & Beyond
PCOS
Renee Jenkins, Howard Univ Coll of Med
Daniel A Dumesic, Reprod Med & Infertility (Washington, DC)
Assoc (Woodbury, MN)
Page content as of January 20, 2007 – for up-to-date information, visit www.endo-society.org/endo/program/index.cfm?view=clinical
Endo2007_KCC TEXT 2/16/07 2:15 PM Page 18
Chair: Selma Feldman Witchel, Children’s Carcinoid Syndrome Management Guidelines for Thyroid
Hosp of Pittsburgh Larry Kvols, Univ of South Florida Nodules & Thyroid Cancer
The Impact of Endocrine-Disrupting GEP Neuroendocrine Tumors in MEN-I Ernest Mazzaferri, Univ of Florida
Chemicals on Female Puberty & Non–MEN-I Patients Molecular Approaches to New Treatment
Jean Bourguignon, Univ of Liege (Belgium) Geoffrey B Thompson, Mayo Clin Modalities
Evolution of Puberty James Fagin, Memorial Sloan-Kettering
Mark Hanson, Univ of Southampton/ The Clinical Future for Vitamin D & Its Cancer Ctr (NY)
Princess Anne Hosp (UK) Analogy C Thyroid Cancer Clinical Trials:
Role of GPR54 Mutations in Pubertal Chair: Roger Bouillon, Katholieke Univ An Update
Disorders Leuven (Belgium) Manisha Shah, Ohio State Univ
Ana Latronico, Hosp das Clinicas da Fac de Regulation of Innate Immune Function by
Medicina da USP (Brazil) Vitamin D & Its Analogues New Directions in Male
John White, McGill Univ (Canada) Hypogonadism C
Sunday, June 3 The Potential Role for Vitamin D & Its (Supported by Solvay)
9:3 0 – 11:00 A M Analogues in Diabetes Management Chair: John K Amory, Univ of Washington
Anastassios Pittas, New England Med Ctr Med Ctr
Clinical Topics in Cardiovascular
(Boston, MA) Sex Steroid Actions in Male Skeleton
Endocrinology C
Role of Vitamin D & Its Analogues in Dirk Vanderschueren, Katholieke Univ
(Supported by Abbott Diagnostics)
Cancer Prevention & Treatment Leuven (Belgium)
Chair: Gail Adler, Brigham & Women’s
David Feldman, Stanford Univ Med Ctr Therapeutic Promise of Selective
Hosp/Harvard Univ
Androgen Receptor Modulators
Clinical Uses of Aldosterone Antagonists
Riccardo Rocha, Novartis Pharmaceuticals 3:4 5 – 5:15 P M (SARMs): Preclinical & Clinical Proof-
Effect of Diet on Diabetes & of-Concept Studies
Corp (East Hanover, NJ)
Metabolism C James Dalton, GTx, Inc (Memphis, TN)
Cardiovascular Pathogenesis of Pre-
(Supported by Sanofi-Aventis) Gonadal Steroids & Cognition in Elderly
Eclampsia
Chair: Kwame Osei, Ohio State Univ Men
S Ananth Karumanchi, Beth Israel
Med Ctr Lenore Launer, NIA/NIH
Deaconess Med Ctr/Harvard Med Sch
New Clinical Considerations in Renin- Is There a Case for the Glycemic Index?
David Jenkins, Univ of Toronto Pathophysiology & Treatment of
Angiotensin Blockade
Does Trans Fat Intake Contribute to Secondary Osteoporosis C
Robert Carey, Univ of Virginia Hlth Syst
Heart Disease & Diabetes? Chair: Ghada El-Hajj Fulheihan, Amer
Martijn Katan,Virje Univ Amsterdam Univ of Beirut Med Ctr
Control of GnRH: The Role of
Genetic Studies in Expanding Our Carbohydrate, Protein & Fat: Getting the Bone Loss Associated with Breast Cancer
Understanding of Neuroendocrine Proportions Right Therapies & Its Management
Mechanisms T Bonnie J Brehm, Univ of Cincinnati Richard Eastell, N Gen Hosp/Univ of
Chair: Kathleen Whitlock, Cornell Univ Sheffield (UK)
Lessons from GPR54 Mutations in Growth Hormone in Aging T Osteoporosis after Organ Transplantation
Idiopathic Hypogonadotropic Chair: Barbara C Hansen, Univ of South Elizabeth Shane, Columbia Univ Coll of
Hypogonadism Florida-Tampa Phys & Surg
Nicolas de Roux, Hosp Robert Debra Maintenance of Cognitive Function in Bone Loss Associated with Inflammatory
(France) Disease & Its Therapies
the Aging Brain by GH
Novel Genes Causing Kallmann’s Steven Goldring, Hosp for Special Surg (NY)
William Sonntag, Wake Forest Univ Sch
Syndrome of Med
Nelly Pitteloud, Massachusetts Gen Hosp The Genetics of Complex Endocrine
GH-Regulated Genes as Markers of Aging Disorders T
Analysis of Kallmann’s Syndrome through John Kopchick, Ohio Univ/Edison Biotech
the Prism of Structural Biology Chair: William Crowley, Harvard Med
Inst Sch/Massachusetts Gen Hosp
Moosa Mohammadi, New York Univ GH & Lifespan in Mammals
Med Ctr Genetics of Type 1 Diabetes
Holly Brown-Borg, Univ of North Dakota Andrew Paterson, Univ of Toronto/Hosp for
Neuroendocrine Tumors of the Sick Children
Gastroenteropancreatic (GEP) Tract C Whole Genome Association Study of
Management of Differentiated Thyroid
Chair: Wouter de Herder, Erasmus Med Ctr Type 2 Diabetes
Cancer C
(Netherlands) David Altshuler, Massachusetts Gen Hosp
Chair: Johannes Smit, Leiden Univ Med Ctr
Pathology of GEP Neuroendocrine Genetic Studies in PCOS
(Netherlands)
Tumors Margrit Urbanek, Northwestern Univ
Guido Rindi, Univ Degli Studi Di Parma Feinberg Sch of Med
(Italy)
Scientific Program
9:3 0 – 11:00 A M in an Animal Model of Alzheimer’s Disease Jill M Siegfried, Univ of Pittsburgh
Roberta Brinton, Univ of Southern California
Controversies in the Management of
Neurosteroids & Alcohol Interactions in Optimal Treatment for Lipid Disorders C
Pituitary Disease C
the Brain (Supported by Pfizer, Inc.)
Chair: Anne Klibanski, Massachusetts
A Leslie Morrow, Univ of North Carolina- Chair: Paulos Berhanu, Wayne State Univ
Gen Hosp
Chapel Hill Sch of Med
Sellar Cysts
Neurosteroids & Feeding Optimal Goals for LDL: What Is the
Edward Laws, Univ of Virginia
Klaus Ossenkopp, Univ of Western Ontario Evidence?
Pituitary Stalk Lesions
(Canada) Alan Chait, Univ of Washington
Mark Molitch, Northwestern Univ Feinberg
Should Triglyceride Be Targeted To
Sch of Med
Polycystic Ovary Syndrome Is Not Reduce Cardiovascular Disease Risk?
Prolactin: Not Just for Lactation
Just a Reproductive Disorder C Helen M Calhoun, Conway Inst (Ireland)
Annice Mukherjee, Christie Hosp (UK)
Chair: Andrea E Dunaif, Northwestern Strategies for Raising HDL levels
Univ Feinberg Sch of Med H Bryan Brewer, Jr, MedStar Res
Emerging Concepts in Testicular
Development & Descent T Cardiovascular Risks in PCOS Inst/Washington Hosp Ctr (Washington, DC)
Chair: Jorma Toppari, Univ of Turku David S Guzick, Univ of Rochester Med Ctr
(Finland) Sleep Apnea in PCOS Perimenopausal Symptoms C
Gubernacular Development David A Ehrmann, Univ of Chicago Chair: Rogerio Lobo, Columbia Univ
John Hutson, Royal Children’s Hosp Res Inst PCOS & Seizure Disorders Med Ctr
(Australia) Martha J Morrell, Stanford Univ Pathophysiology of Menopausal Hot
Developmental Origin of Human Flashes
Weight Loss Maintenance: Preventing Robert Freedman, Wayne State Univ
Testicular Cancer: Environmental &
Weight Regain C Cognitive Changes in Menopause & the
Genetic Aspects
(Supported by Sanofi-Aventis) Effects of Treatment
Ewa Rajpert-De Meyts, Univ Hosp of
Chair: Karen Foster-Schubert, VA Puget Pauline Maki, Univ of Chicago-Illinois
Copenhagen
Sound Hlth Care Sys/Univ of Washington The Perimenopause: Interrelated
Preservation of Spermatogenesis in
Behavioral Aspects of Weight Regain Symptoms & Responses to Treatment
Cryptorchidism
Suzanne Phelan, Brown Univ/The Miriam Hadine Joffe, Massachusetts Gen Hosp
Kolja Kvist, Univ Hosp of Copenhagen
Hosp
Physiology of the Reduced Obese State Pheochromocytoma & Paraganglioma C
Extension of Human Lifespan &
Holly Wyatt, Univ of Colorado Hlth Sci Ctr Chair: Shern Chew, St Bartholomew’s Hosp
Prevention of Aging T
Pharmacotherapy to Avoid Weight Regain (UK)
Chair: Reubin Andres, NIA/NIH
Robert Lustig, Univ of California-San Hereditary Paraganglioma: An Emerging
The GH-IGF Axis in Aging: Lessons from
Francisco Link between Krebs Cycle & Hypoxic
Individuals with Exceptional Longevity
Signaling
Pinchas (Hassy) Cohen, Univ of California-
Los Angeles
3:4 5 – 5:15 P M Bora Baysal, Univ of Pittsburgh
Long-Term Consequences of Early Genetic Regulation of Succinate
Aging & Longevity Genes
Glucocorticoid Exposure C Dehydrogenase & Paraganglioma
Rudi Westendorp, Leiden Univ Med Ctr
Chair: Sharon Oberfield, Columbia Univ Susceptibility
(Netherlands)
Coll of Phys & Surg Patricia Dahia, Univ of Texas Hlth Sci Ctr
Aggressive Dietary & Lifestyle
Early Cortisol Biosynthesis by the Human Novel Approaches to Imaging & Therapy
Approaches to Longevity
Fetal Adrenal Cortex During Sexual for Pheochromocytoma & Paraganglioma
Samuel Klein, Washington Univ Sch of Med
Differentiation Wouter de Herder, Erasmus Med Ctr
Neil Hanley, Univ of Southampton (UK) (Netherlands)
Modeling Hormone-Dependent
High-Dose Glucocorticoid Administration
Cancers T
in Late Gestation Tuesday, June 5
Chair: Wayne D Tilley, Univ of
Keith J Barrington, Royal Victoria Hosp 9:3 0 – 11:00 A M
Adelaide/Hanson Inst (Australia)
(Canada)
Modeling Progesterone Receptor- Cushing’s Syndrome C
Long-Term Follow-Up of Fetuses
Dependent Cancers Chair: Beverly MK Biller, Massachusetts
Prenatally Treated for CAH
Eva Lee, Univ of California-Irvine Gen Hosp
Svetlana Lajic, Imperial Coll (UK)
PSA Induces Epithelial-to-Mesenchymal Endogenous Hypercortisolism: Not your
Transition (EMT) in Prostate Cancer Mentor’s Cushing’s Syndrome
Novel Mechanisms of Hormone
Judith Clements, Queensland Univ of Tech Action in Cancer T James Findling, St Luke’s Med Ctr
(Australia) Chair: Irma Russo, Fox Chase Cancer Ctr (Milwaukee, WI)
IGF-1 in Prostate & Breast Cancers (Philadelphia, PA) Role of cAMP/PKA Signaling Pathway in
Shoshana Yakar, Mt Sinai Sch of Med Endocrine Resistance in Breast Cancer Cushing’s Syndrome
Rakesh Kumar, Univ of Texas MD Anderson Constantine Stratakis, NICHD/NIH
Neurosteroid Biosynthesis & Actions Molecular Genetics of Adrenal Cortical
Cancer Ctr
in the Brain T Page content as of January 20, 2007 – for up-to-date information visit
Carcinoma
Epigenetics in Prostate Cancer
Chair: Synthia Mellon, Univ of California-
www.endo-society.org/endo06/Program/clinical.php Jerome Bertherat, CHU Cochin (France)
Gail Prins, Univ of Illinois-Chicago
San Francisco
Page content as of January 20, 2007 – for up-to-date information, visit www.endo-society.org/endo/program/index.cfm?view=clinical
Endo2007_KCC TEXT 2/16/07 2:17 PM Page 20
Page content as of January 20, 2007 – for up-to-date information, visit www.endo-society.org/endo/program/index.cfm?view=clinical
Endo2007_KCC TEXT 2/16/07 2:17 PM Page 21
Scientific Program
11:15 A M – 12:15 P M Congenital Adrenal Hyperplasia Genetic & Clinical Insights
Deborah Merke, NICHD/NIH Alan Burshell, Ochsner Clin Fdn (New
What Should Be the Target for
Glycemic Control in the ICU? E Orleans, LA)
Cushing’s Syndrome
Moderator: John Buse, Univ of North John Newell-Price, Sheffield Univ (UK) Osteoporosis Management in Men
Carolina Sch of Med (Supported by Eli Lilly & Company)
Treatment Strategy 1: To Less than 110 Cushing’s Syndrome in Children & Benjamin Leder, Massachusetts Gen Hosp
mg/dL Adults
Greet Van den Berghe, Katholieke Univ Ashley Grossman, St Bartholomew’s Hosp (UK) Screening for & Treating Vitamin D
Leuven (Belgium) Deficiency: What’s the Target?
Treatment Strategy 2: To 120–150 mg/dL Disorders of Steroidogenesis, Other (Supported by Quest Diagnostics)
John Miles, Mayo Clin than 21-Hydroxylase Daniel Bikle, Univ of California-San
Kenji Fujieda, Asahikawa Med Coll (Japan) Francisco VA Med Ctr
Monday, June 4 Evaluation of Adrenal Function in Use of Bone Markers in Osteoporosis
11:15 A M – 12:15 P M the ICU (Supported by Eli Lilly & Company)
What Is the Role of FNA in the Mark Cooper, Univ of Birmingham (UK) Richard Eastell, Northern Gen Hosp/Univ of
Management of the Thyroid Nodule: Sheffield (UK)
Case 1— Incidentally Discovered Inherited Adrenal Disease
Solitary Thyroid Nodule; Case 2— John Achermann, Inst of Child Hlth/Univ Diabetes
Euthyroid Multinodular Goiter E Coll London (UK) Diabetes & Pregnancy
Moderator: David Cooper, Sinai Hosp of Boyd Metzger, Northwestern Univ Med Sch
Baltimore Management of the Adrenal
Treatment Strategy 1: Selective Use of Incidentaloma Diabetes Mellitus in African-American
FNA John Connell, Univ of Glasgow (Scotland) Children & Adolescents
Susan Mandel, Univ of Pennsylvania (Supported by Eli Lilly & Company)
Metastatic Pheochromocytoma
Treatment Strategy 2: FNA for All Gabriel Uwaifo, MedStar Res Inst
Karel Pacak, NICHD/NIH
Nodules (Washington, DC)
Bryan McIver, Mayo Clin Mineralocorticoid Hypertension
Diabetes: When & How To Use Insulin
Paul Stewart, Univ of Birmingham (UK)
(Supported by Eli Lilly & Company)
Tuesday, June 5
Nelson’s Syndrome & Cushing’s David Nathan, Harvard Med
11:15 A M – 12:15 P M Sch/Massachusetts General Hosp
Disease
Is There a Role for DHEA Xavier Bertagna, Hopital Cochin (France)
Replacement Therapy? E Diabetic Neuropathy
Moderator: D Lynn Loriaux, Oregon Hlth Nonclassical Congenital Adrenal Eva Feldman, Univ of Michigan
Sci Univ Hyperplasia in Adults
Yes, There Is a Role for DHEA Ricardo Azziz, Cedars-Sinai Med Ctr Effect of Diabetes Treatments on
Replacement Therapy Pancreatic Function
Wiebke Arlt, Univ of Birmingham Pheochromocytoma Robert Zimmerman, Cleveland Clin
No, There Is No Role for DHEA Shern Chew, St Bartholomew’s Hosp (UK)
Hypoglycemia: Challenging Cases
Replacement Therapy Primary Aldosteronism F John Service, Mayo Clin
Richard Auchus, Univ of Texas SW Med Ctr
Michael Stowasser, Princess Alexandra Hosp
Incretins & DPP-IV Inhibitors: Uses &
(Australia)
Pitfalls in Treating Diabetics
Meet-the-Professor Bone/ Calcium Daniel Drucker, Mt Sinai Hosp
Bone Loss in Transplantation Patients
Sessions Elizabeth Shane, Columbia Univ Coll of New Drugs & Diabetes Risk:
Hear first hand from recognized thought Antipsychotic & Antiretroviral Agents
Phys & Surg
leaders in endocrine practice. The Meet- Samuel Dagogo-Jack, Univ of Tennessee-
the-Professor Sessions will include expert Hyperparathyroidism Memphis
speakers in all of these endocrine practice (Supported by Quest Diagnostics)
areas: adrenal, bone/calcium, diabetes, Novel Approaches to Treatment of
John Bilezikian, Columbia Univ Coll of Phys
female & male reproduction, obesity/lipids, Diabetes Complications
& Surg
pediatrics, pituitary, thyroid, and miscella- (Supported by Takeda Pharmacueticals North
neous categories. Hypocalcemia America, Inc.)
Bart Clarke, Mayo Clin Byron Hoogwerf, Cleveland Clin Fdn
B C T E
21
Basic Clinical Translational Ethics
Endo2007_KCC TEXT 2/16/07 2:18 PM Page 22
Scientific Program
Postpartum 1:3 0 – 5:3 0 P M
(Supported by Abbott Laboratories) Education Services Using CGM to Improve Diabetes Care:
Alex Stagnaro-Green, Univ of Med & Dent Continuing Medical Education Services A Review of the Latest Research &
of New Jersey (CMES), a division of The Endocrine Clinical Practice Strategies
Society, develops a variety of superior (Cosponsored by The Endocrine Society &
Thyroid Hormone Therapy: Why Some continuing medical education activities The Juvenile Diabetes Research Foundation;
Patients Are Unhappy that are presented as ancillary symposia to Supported by Abbott Diabetes Care &
(Supported by Abbott Laboratories) the ENDO Meeting. Medtronic Minimed, Inc.)
David Cooper, Sinai Hosp of Baltimore Program Directors: Jennifer Larsen, MD &
The Endocrine Society is accredited by
Thyroid Nodules the Accreditation Council for Continuing Aaron Kowalski, PhD
Stephanie Fish, Univ of Pennsylvania Medical Education (ACCME) to provide
continuing medical education for 6:3 0 – 9:3 0 P M
Thyroiditis: Unusual Causes/Unusual physicians. Endocrine Sequelae in Post-Traumatic
Cases Brain Injury
Robert Smallridge, Mayo Clin-Jacksonville CMES programs are developed by The (Supported by Novo Nordisk Inc.)
Endocrine Society’s Special Programs and Program Director: Anne Klibanski, MD
Unusual Causes of Hypothyroidism CME Advisory Committees, ensuring
Paolo Beck-Peccoz, Inst of Endo Scis (Italy) that content is balanced, free from Saturday, June 2
commercial bias, and maintains the 6:00 – 8:00 A M
Miscellaneous Society’s standard of scientific integrity.
Endocrine Evaluation of the Patient The Role of Inhaled Insulin in Current
These programs are supported by Therapeutic Practice
with Fatigue educational grants from industry. The
Simon Aylwin, King’s Coll Hosp (UK) (Supported by Pfizer, Inc.)
Society ensures that all are in strict Program Director: To Be Announced
John Miell, Univ Hosp Lewisham (UK) compliance with ACCME and American
Endocrinopathies of Sickle Cell Disease Medical Association (AMA) guidelines. Thyroid Disease & Pregnancy
Guillermo Umpierrez, Emory Univ Sch of Med These continuing medical education (Supported by Abbott Laboratories)
activities have been planned and Program Director: To Be Announced
Ethical Dilemmas in Hormone implemented in accordance with the
Clinical Outcome of Hyponatremia
Replacement Therapy E Essential Areas and Policies of the ACCME.
(Supported by Otsuka America
Paul Komesaroff, Monash Univ (Australia) For Disclosure Policy and Policy on
Pharmaceutical, Inc.)
Unlabeled/Off-Label Usage, refer to
Flushing & Sweating Continuing Medical Education (CME) Program Director: To Be Announced
Pierre-Marc Bouloux, Royal Free Hosp (UK) Accreditation on page 25 of this program.
6:3 0 – 9:00 P M
Meet the Editor-In-Chief of The Journal This event is approved by the Canadian Minority Involvement Clinical
of Clinical Endocrinology & Metabolism Society of Endocrinology and Metabolism Research Symposium & Dinner
Paul Ladenson, John Hopkins Univ Sch of Med as an Accredited Group Learning Activity (Supported by the Robert Wood Johnson
MEN 1 (Section 1) as defined by the Maintenance Foundation)
Stephen Marx, NIDDK/NIH of Certification program of The Royal Program Director: Maria Alexander-
College of Physicians and Surgeons Bridges, MD
MEN 2 of Canada.
Robert Gagel, Univ of Texas MD Anderson 6:3 0 – 9:3 0 P M
Cancer Ctr Managing Multiple Cardiovascular
C M E S Ancillary Symposia
Programs are subject to change. Space is Risk Factors: Focus on Obesity,
Molecular Biology for the Clinician
Overweight & Type 2 Diabetes
John Kopchick, Ohio Univ/Edison Biotech Inst available on a first-come, first-served basis
(Supported by Sanofi-Aventis)
for registered physicians and allied health
Pearls from an Endocrine Surgeon Program Director: To Be Announced
professionals. There is no cost to attend.
Cord Sturgeon, Northwestern Univ Feinberg All programs will be held at the Fairmont Novel Targets for Diagnosis &
Sch of Med Royal York or the Westin Harbour Castle Treatment of Endocrine Neoplasia
Transsexualism: The Endocrinologist’s except for the CGM Workshop, which (Supported by The Endocrine Society
Role will be held at the Metro Toronto Corporate Liaison Board)
Thomas Murphy, Metrohealth Med Ctr Convention Centre. Program Director: Campbell P Howard, MD
(Cleveland, OH)
What To Do with the Patient with
Idiopathic Edema
John Monson, London Clin Ctr for Endo
B C T E
23
Basic Clinical Translational Ethics
Endo2007_KCC TEXT 2/21/07 2:57 PM Page 24
6:00 – 8:00 A M sessions during the four-day meeting. New this year, there will be
Growth Hormone Related Disorders: Molecular Genomics
& Clinical Implications four days of poster presentations. Sessions will be assembled from
(Supported by GATE Pharmaceuticals) the more than 2,600 abstracts received for consideration. The
Program Director: David R Brown, MD Annual Meeting Steering Committee reviews and schedules the
best abstracts in these sessions in early February. Check the
Stressing Glycemic Constancy: The New Paradigm in ENDO 07 Web site for the oral and poster session schedule.
Diabetes Care
(Supported by Eli Lilly & Company) Oral & Poster Session Categories
Program Director: Jerry Palmer, MD
Adipokines, Appetite & Obesity
Management of Metabolic Bone Disease in Patients with Adrenal Axis
Chronic Kidney Disease Aging
(Supported by Abbott Renal) Bone & Mineral Homeostasis
Program Director: Paul Miller, MD Cardiovascular Endocrinology
Case Reports
6:3 0 – 9:3 0 P M Diabetes & Glucose Metabolism
Incretin Agonists & DPP-IV Inhibitors: Novel Approaches Effects of Hormones on Cancer
in the Treatment of Type 2 Diabetes Endocrine Disruption
(Supported by Merck & Co., Inc.) Endocrine Genetics
Program Director: Bernard Zinman, MD, FACP, FRCP Endocrine Neoplasia & Tumors
Endocrine Nursing
Prolactinomas, Cushing’s & Acromegaly: An Update in Evolutionary & Developmental Endocrinology
Medical Therapy for Pituitary Adenomas Female Reproductive Endocrinology
(Supported by Novartis Pharmaceuticals) Fetal Placental Physiology
Program Director: Beverly Biller, MD Gene Expression
Co-Chair: Marco Boscaro, MD Growth Hormone & Prolactin Biology
Health Care Delivery
Aggressive Non-iodine Avid Thyroid Cancer Hormones & Immunity
(Supported by Amgen) Inhibins-Activins-TGF-Beta Superfamily
Program Director: Ernest Mazzaferri, MD Insulin-Like Growth Factors
Male Reproductive Endocrinology
Monday, June 4 Neuroendocrinology
6:00 – 8:00 A M Pediatric Endocrinology
Hyponatremia: State of the Art Clinical Pituitary
(Supported by Astellas Pharma US, Inc.) Signaling
Program Director: Gary Robertson, MD Steroid Superfamily: Hormones, Receptors & Actions
Thyroid
Treatment of Hypogonadism
(Supported by Indevus Pharmaceuticals, Inc.)
Program Director: To Be Announced
6:3 0 – 9:3 0 P M
Beyond Surgery: The Role of Medical Therapy in
Acromegaly
(Supported by Tercica, Inc.)
Program Director: Pamela Freda, MD
Tuesday, June 5
6:00 – 8:00 A M
Changing Paradigms in the Treatment of Type 2
Diabetes: Results From Recent Pivotal Trials
(Supported by Takeda Pharmaceuticals North America, Inc.)
Program Director: Edward Horton, MD
Continuing Medical
EDUCATION
Scientific Program
Accreditation The Endocrine Society has reviewed this activity’s speaker
The Endocrine Society is accredited by the Accreditation disclosures and resolved or managed all identified conflicts of
Council for Continuing Medical Education (ACCME) to provide interest, if applicable.
Continuing Medical Education (CME) for physicians.
Faculty disclosures will be printed in the ENDO 07 Program &
The Endocrine Society designates this educational activity for a Abstracts Book and in the Meeting & Exhibit Guide.
maximum of 37.0 AMA PRA Category 1 CreditsTM. Physicians
should only claim credit commensurate with the extent of their Policy on Unlabeled/ Off-Label Usage
participation in the activity. The Endocrine Society has determined that disclosure of unlabeled/
off-label or investigational use of commercial products is informative
Statement of Need for audiences and therefore requires that this information be dis-
Endocrinologists need a thorough knowledge of the most recent closed to the learners at the beginning of the presentation.
developments and techniques in endocrinology to ensure the
standard of patient care. Specific medicines discussed in this program may not yet be
approved and/or may not be specified to be used as indicated by
Learning Objectives the speaker. Before prescribing any medication, review the complete
Upon completion of this educational activity, participants should prescribing information, including indications, contradictions,
be able to: warnings, precautions, and adverse effects.
• Discuss state-of-the-art research in endocrinology
• Demonstrate updated knowledge of the diagnosis and Commercial Support
treatment of diabetes, osteoporosis, pediatric, thyroid and This activity is being supported by various commercial entities.
reproductive endocrine disorders The supporters will be acknowledged in the ENDO 07 Program &
• Employ enhanced skills and practice management techniques Abstracts Book and Meeting & Exhibit Guide. The Endocrine
to improve patient care Society gratefully acknowledges their generous support for this
educational activity.
Target Audience
The continuing medical education activity should be of The Endocrine Society takes responsibility for the content, quality,
substantial interest to: and scientific integrity of this CME activity. This activity has
been planned and implemented in accordance with the Essential
• Endocrinologists
Areas and Policies of the ACCME. The ENDO 07 scientific program
• Pediatric endocrinologists
was developed by the Annual Meeting Steering Committee prior
• Internists
to and independently of educational grant support. The commer-
• Clinical researchers
cial supporters of this meeting have no influence over topics or
• Other endocrine professionals
speakers. Educational grants support the overall meeting and are
not used to compensate speakers in supported sessions.
Disclosure Policy
As a provider of continuing medical education accredited by the
Accreditation Council for Continuing Medical Education
Getting Your C M E Credits or Certificate of
(ACCME), it is The Endocrine Society’s policy to ensure that the
Attendance
Registrants are to visit the designated CME and Evaluation stations
content and quality of this educational activity are balanced,
and complete their post-program evaluation form online. Once
independent, objective, and scientifically rigorous. All faculty
you have completed the evaluation, you may print your CME
participating in the CME activity are expected to disclose to the
Certificate and/or your Certificate of Attendance directly from
learners any significant financial interest or relevant financial
the computer in use. The ENDO 07 CME Certificate and
relationship(s) with the commercial supporters of the activity that
Evaluation service will also be available online after the meeting.
have occurred within the last 12 months. Such relationships may
include grants, research support or participation in industry-
This event is approved by the Canadian Society of Endocrinology
sponsored research, stock ownership, employment, consultation
and Metabolism as an Accredited Group Learning Activity
or participation in speakers bureaus and boards of directors. The
(Section 1) as defined by the Maintenance of Certification program
intent of this disclosure is not to prevent a speaker with significant
of The Royal College of Physicians and Surgeons of Canada.
financial or other relevant relationships from making a presentation
but rather to provide learners with information on which they
can maketheir own judgments. It remains for the learners to
determine whether the speaker’s interests or relationships may
influence the presentation with regard to exposition or conclusion.
Professional Development
OPPORTUNITIES
Fellow & Student Reception Career Development Workshops
Friday, June 1 Saturday, June 2 – Tuesday, June 5
6:00 – 7:30 PM The 9th Annual Career Development Workshop, developed
All fellows and students attending ENDO 07 are invited to this by the Trainee Development Committee, has evolved to further
popular event. Catch up with colleagues and friends, enjoy light meet the needs of trainees. Rather than a single event that
refreshments, and join The Endocrine Society in honoring all precedes ENDO, this year’s workshop will feature sessions on
ENDO travel grant recipients. Indicate your interest in attending career development topics scheduled throughout the entire meeting,
this reception by marking the appropriate box on the ENDO 07 with two or three sessions each day. Each session will target
Registration Form (see page 45). specific constituencies as well as provide networking and
Contact: Danielle Jordan at djordan@endo-society.org or professional development opportunities in an intimate environment.
301.951.2616. ENDO Registrants can attend any of the following sessions:
Employers: Fill a vacant position Ethics in Publishing: The information in this lecture will help
• Post an unlimited number of job descriptions at ENDO 07 you navigate the process of ethically publishing your endocrine
• Receive CVs of every candidate registered with the Job Fair research.
(over 100 expected)
• Post your job descriptions on The Endocrine Society Web site Interviewing Skills: This informative session will assist you in
• Interview candidates of your choice successfully interviewing for each advancement in your career.
(Employers not attending ENDO 07 can benefit from all of the Meet the Editors-in-Chief: Network with the Editors-in-Chief
above, except interviews.) of The Endocrine Society’s peer-reviewed journals.
Candidates: Find a new professional setting Meet the President & President-Elect: Network with
• Receive copies of all job descriptions posted at ENDO 07 Endocrine Society President Leonard Wartofsky and President-
• Post your CV on The Endocrine Society Web site Elect Margaret Shupnik.
• Attend on-site interviews.
(Candidates not attending ENDO 07 can benefit from all of the Meet the Trainee Development Committee: Find out what it
above except interviews.) takes to participate in Society leadership. Meet past, present, and
incoming members of the Trainee Development Committee,
which is comprised of and chaired by trainees.
Registration Fees (All rates in USD)
Employer Attending $400 Mock Study Section: A panel will go through the step-by-step
Employer Not Attending $340 process of study section.
Candidate In-Training $ 15
Setting Up a Lab: Learn the necessary skills to set up your first
Candidate Members $ 25 lab, including the unique challenges and common pitfalls to
Candidate Nonmember $ 50 avoid.
Contact: Colleen Gorman at cgorman@endo-society.org or
To register, visit www.endo-society.org/placementservices. On-site 301.951.2611.
registration will also be available.
Contact: Christine Whorton at placement@endo-society.org or
800.361.3906 or 520.544.2760.
All programs will be held in The Metro Toronto Convention Centre unless otherwise noted.
Endo2007_KCC TEXT 2/16/07 2:25 PM Page 27
Conference
EVENTS
Satellite Meetings Increasing Minority Involvement in
Friday, June 1
7:30 AM – 7:00 PM
Clinical Research Dinner
Saturday, June 2
Westin Harbour Castle
6:30 – 9:00 PM
5th Annual Meeting of the Androgen Excess Society (AES)
Fairmont Royal York
The Androgen Excess Society Annual Meeting is held in
conjunction with ENDO 07. The 2007 AES meeting format is A lively, wide-ranging, and informative panel-led discussion
designed to deliver cutting-edge research while serving as an on issues related to minority involvement in clinical research.
Speakers include Kenneth A Getz, Alfonso Alanis, MD, James R
international forum for physicians and scientists interested in
Gavin III, MD, PhD, representatives of funding/regulatory
disorders of androgen excess, such as polycystic ovary syndrome,
agencies, and members of the Society’s task force on eliminating
congenital adrenal hyperplasia, idiopathic hirsutism, and disparities in clinical trials.
premature adrenarche.
For registration, program information, and abstract submissions Corporate Liaison Board Forum
and deadlines, visit www.ae-society.org or contact Faye Byrd at Saturday, June 2
faye.byrd@cshs.org. Registration fees: AES Members $100; 6:30 – 9:30 PM
nonmembers $150. Fairmont Royal York
The Forum, hosted by the Corporate Liaison Board, will focus on
novel targets for diagnosis and treatment of endocrine neoplasia,
Exploring Strategies to Increase Minority with speakers from industry, academia, and government discussing
new technologies, biomarkers, and targeted molecular therapies.
Involvement in Clinical Research
Symposium Novel Targets for Diagnosis and Treatment of
Endocrine Neoplasia
(Supported by the Robert Wood Johnson Foundation)
Saturday, June 2 Introductory Remarks: Campbell P Howard, MD, Program Director
9:30 – 11:00 AM Therapeutic Utility of Somatostatin Analogs in Endocrine Neoplasia
Mounting evidence of ethnicity-specific differences in response Michael Culler, MS, PhD, Ipsen, Dept of Endo Research
to therapeutics, as well as expression of risk markers that inform Multiple Endocrine Neoplasia Type 1: Targeting the Humors &
treatment, demands that more be done to determine the scope Tumors
and basis of such differences. Achieving statistically powerful Stephen Marx, MD, Metabolic Dis Branch, NIDDK/NIH
subpopulation analysis requires that we eliminate disparities in Nuclear Hormone Receptors as Targeted Thereapy in
clinical trial participation. Best practices for increasing involvement Thyroid Cancer
of minority groups — developed by stakeholders in the community, Bryan Haugen, MD, Univ of Colorado Hlth Sci Ctr
academia, industry, and government — will be presented with a Contact: Nancy Chill at nchill@endo-society.org.
focus on increasing participation of minority physicians in
clinical research as an efficient means of reaching the minority
research volunteer.
Women in Endocrinology Dinner
Saturday, June 2
6:30 – 10:00 PM
This project began with a session during ENDO 06 in which Westin Harbour Castle
several speakers shared their experiences with recruitment in the More details to come; see the ENDO 07 Web site for updates and
academic and corporate settings. Speakers for ENDO 07 include more information. Contact Julie Sharpless for more information
Kenneth A Getz, MBA, chairman of CISCRP, and Dr Alfonso or special dietary requests at 919.966.1254 or
Alanis, CEO of Anaclim, who will discuss efforts to document julie_sharpless@cceb.med.upenn.edu.
and dispel impediments to participation of minority physicians
in clinical research. The Society’s recommendations will be
presented for subsequent discussion at the Clinical Research
Dinner to be held the same evening.
All programs will be held in The Metro Toronto Convention Centre unless otherwise noted.
Endo2007_KCC TEXT 2/22/07 10:34 AM Page 29
CONFERENCE EVENTS
Closing Reception
Tuesday, June 5
6:30 – 8:00 PM
All attendees and their registered guests are invited for an
evening filled with dancing complemented by elegant hors d’oeu-
vres and cocktails. To register, check the appropriate box
on the Registration Form (see page 45).
Registration,
HOTEL, TRAVEL
Registration, Hotel, Travel
REGISTRATION INFORMATION
Key Dates & Deadlines Registration Fees (all rates in U S D)
Early Registration April 7 Early Registration: April 7
Advance Registration May 11
Receipt of Cancellation to Receive Refund May 11 Member Nonmember Member Savings
Last Day to Apply for Membership to Professional $375 $780 $405
Receive Discounted Meeting Rates May 14 In-Training $190 $325 $135
On-site Registration Opens June 1
Emeritus $0 n/a n/a
ENS Nurse $375 $780 $405
Methods of Registration One Day Only $215 $275 $60
Early Registration: Register early and save 20%. In
Guest/Spouse $90 $90 n/a
addition, you will receive the ENDO 07 abstracts on CD-
ROM (Abstracts2ViewTM) prior to the meeting. Use any Advance Registration: May 11
of the following registration methods by April 7 to take
Member Nonmember Member Savings
advantage of this offer:
Professional $515 $990 $475
Mail: ENDO 2007 Registrar
c/o Laser Registration In-Training $275 $415 $140
1200 G Street, NW, Suite 800 Emeritus $0 n/a n/a
Washington, DC 20005-3967 ENS Nurse $515 $990 $475
Fax: 888.695.5498 (domestic) One Day Only $280 $335 $55
514.228.3202 (international) Guest/Spouse $90 $90 n/a
Page content as of January 20, 2007 – for up-to-date information, visit www.endo-society.org/endo/registration
Endo2007_KCC TEXT 2/16/07 2:34 PM Page 31
REGISTRATION INFORMATION
Discounted Registration Rates Letter of Invitation
HOTEL INFORMATION
Registration, Hotel, Travel
Endo2007_KCC TEXT 2/16/07 2:36 PM Page 33
HOTEL INFORMATION
Hotel List & Rates
s i n g B l ock – a r t e r H otels –
r o u g h the Hou fits: a t t h
u
e H e a d q n M o re :
h
B o o k T R e a p t h e Bnevennetion center Boo k Eve
oom c
Benefit tion cen
en
tre
ice to/fr of conv s
hut tle serv
ttendee
s
ing distance CMES program
• Free s es available tion of a in walk nding
at nc entra • With ience in atte
• Best r king—high co en
N etw or • Conv
•
HOTEL INFORMATION
Key Dates & Deadlines Group Housing Reservations
Registration, Hotel, Travel
Group Housing Request April 7 Group Housing reservations must be made through the ENDO
Housing Request May 4 2007 Registrar. Call 888.695.5481 or 202.347.6659 or email
ENDO@Laser-Registration.com and state that you are requesting
a group (10 or more registrants required). The Group Housing
E N D O 07 Housing Block
Request Form, deposit payment, and signed Group Housing
Reap the Benefits
Agreement must be received by the Housing Bureau prior to
Book your hotel reservation through the ENDO 07 Housing Block
April 7.
and reap the benefits. You will receive the best rates, free shuttle
service to/from convention center, and optimal networking
opportunities due to the high concentration of attendees staying Reservation Confirmation
within the block. You will receive an email, fax, or letter confirming your
accommodation within 15 days of receipt of complete reservations.
When you book at the Headquarter Hotels, you will benefit even Confirmations will not be given over the telephone. If you have
more because they are not only within walking distance to the submitted a Housing Request Form and registered for ENDO 07,
convention center, but also are convenient for attending CMES but have not received a confirmation within 15 days, email the
Ancillary Symposia, which are located within these hotels. Housing Bureau at ENDO@Laser-Registration.com.
Super Discounted Rates for Students Please do not call your hotel until after May 11, as processing
All rates are discounted through the ENDO 07 Housing Block, your reservations from the Housing Bureau into the Hotel System
but we have negotiated super discounted rates for students that will take a few days. If you have received a confirmation number
book within the Delta Chelsea Hotel. This not only provides an from the Housing Bureau, the hotel will honor your booking.
opportunity to save, but also opens the doors for four full days
of networking with your peers.
Web: https://www.-stop-registration.com/endo/
TRAVEL INFORMATION
Getting to Toronto ATC Online Travel Center
Rail: VIA Rail and AMTRAK bring visitors into the heart of the Customs – Travel Made Easy
city each day. Toronto’s Union Station is located centrally We have assembled some of the frequently asked questions about
downtown, one block from the Metro Toronto Convention Centre travel to/from Canada and the resources you should rely on to
within easy walking distance from most ENDO 07 hotels. make your travel a snap.
Road: Several major highways link the surrounding cities to Do I need a passport and/or visa to travel to/from
Toronto. ENDO 07 is just a day’s drive from the following US cities: Canada?
Buffalo, Cleveland, Detroit, Pittsburgh, Rochester, and Syracuse.
US Citizens: Beginning January 23, 2007, the US government will
be requiring that each US citizen and permanent resident traveling
Discount Travel Reservations outside of the US by air must carry a valid US passport or other
Association Travel Concepts (ATC) is the official travel agency secure travel document such as a NEXUS Air card. All children,
for ENDO 07. ATC provides personalized service, advance seat regardless of age, must have their own passport to enter the US.
assignments, special meal requests, frequent flier program updates, Info: www.travel.state.gov/travel/cbpmc/cbpmc_2223.html
electronic ticketing, email access for convenient booking of your
tickets, and more. Non-US Citizens: Must carry a valid passport and visa. Citizens
from the United Kingdom, France, Germany, Mexico, Japan, the
Airline Discounts Republic of Korea, Australia, and others do not require a visa to
• Up to 15% off applicable classes of service for tickets purchased enter Canada. Contact a Canadian embassy, high commission, or
more than 30 days prior to the meeting. Restrictions apply consulate for information on what you will need before coming to
and not all classes of service receive the 15% discount Canada.
(United) Info: www.canadainternational.gc.ca/SBPage.aspx?pageid
• 5% off applicable classes of service for tickets purchased prior =665&lang=en#2
to the meeting (American Airlines)
• Multiple discounts available (Air Canada) What are the Canadian entry requirements for children?
• ATC will also search for the lowest available fare on any
airline If you are traveling with children under 18 years, you should carry
• You may also call your own agency or the vendors directly identification for each child, such as a birth certificate or green
and refer to the following ID numbers: card. Children traveling without their parents, with one parent,
United 510CK 800.521.4041 or with guardians should carry written permission. Divorced
American Airlines A2557AE 800.433.1790 parents with shared custody rights should carry legal documents
Air Canada 3EG3A7D1 800.361.7585 establishing their status.
Info: www.cbsa.gc.ca/E/pub/cp/rc4161/rc4161-e.html#P004
Car Discounts
• Avis & Enterprise What can delay or prohibit my entry into Canada?
• You may also call your own agency or the vendors directly You may not be permitted to enter Canada if you have a criminal
and refer to the following ID numbers: conviction, including a conviction for driving while impaired.
Enterprise 32H7476 800.593.0505 Info: www.cic.gc.ca/english/visit/inadmissibility.html
Avis J952801 800.331.1600
What are the US re-entry requirements for non-US citizens
Methods of Travel Reservation studying/working in the US?
Email: reservations@atcmeetings.com Make sure that your visa allows for multiple re-entries into the
US. If your return trip also involves a connection in the US, you
Fax: 858.362.3153 may need a visa for the trip to Toronto and another for the
return. Each stop may be counted as one entry and exit.
Web: www.atcmeetings.com/endocrine Info: www.cbp.gov/xp/cgov/travel/id_visa/
TRAVEL INFORMATION
Where can US Citizens get a US passport? Hail a Taxi
Registration, Hotel, Travel
First-time passport applicants need to apply for their passport in • Fares are standard, metered, and non-negotiable
person. Passport renewals can be done by mail if your most recent • The driver should start the meter at the beginning of your
passport is available to submit and is not damaged; you received ride and stop it when you reach your destination
the passport within the past 15 years; you were over age 16 when • Refuse to ride in a taxi without an operational meter
it was issued; you still have the same name, or can legally • If your service was acceptable, a 10% – 15% tip is customary
document your name change.
The Underground City
Info: http://travel.state.gov/passport/passport_1738.html PATH is Toronto’s underground walkway linking 27 kms (16
miles) of subterranean shopping, services, and entertainment.
Online Travel Resources Follow the brightly colored PATH signs and you’ll reach your
US Department of State: downtown destination easily in weatherproof comfort.
www.state.gov/travelandbusiness/ What to See & Do
Canada International: With Toronto’s bounty of theatres, attractions, museums, art
www.canadainternational.gc.ca/gtc/Going_To_Canada-en.aspx galleries, theme parks, markets, and even its very own islands,
there’s plenty of inspiration for your personal Toronto itinerary—
whether you like to preplan or discover as you go. Whatever you
Toronto Guide do, don’t forget to send postcards home. To search for more things
Toronto is an “intimate metropolis” with world-class dining, to see and do in Toronto, visit
shopping, innovation, architecture, and entertainment. From the www.mytorontomeeting.com/Visitor/WhatToSeeAndDo.
awe-inspiring CN Tower to the distinct, personality-rife
neighborhoods, Toronto caters to a vast array of interests, cultures,
and palates. Toronto Tours
To register for any of the Toronto Tours, complete the Tour
Sample a few of the more than 7,000 restaurants reflecting Registration Form on page 49.
cuisines from around the world or delight in shopping at the
trendy Queen Street West. Unwind as you traverse the lovely Daily Wake-Up Walks
waterfront or immerse yourself in a live theatre show. Venture Saturday, June 2 – Monday, June 4
outside of the city limits, and experience the wonder of Niagara 6:30 – 7:30 AM
Falls, a renowned wine region, and many intriguing outdoor
adventures. Complimentary
Join us each morning for a one-hour walking tour of Toronto’s
No matter what you choose to do during your visit, Toronto downtown. See sights such as the Financial District, Chinatown,
engages your imagination with an experience unlike any the or even the PATH. The PATH is downtown Toronto’s
world over. underground walkway linking 27 kilometers of shopping,
services, and entertainment.
Languages Spoken
There are two official Canadian languages—English and French.
Worlds within Toronto Neighborhood Tour, Including the
In addition to these, the top five languages spoken in Toronto are
CN Tower
Chinese, Italian, Tamil, Portuguese, and Spanish.
Saturday, June 2
Getting Around 9:00 AM – 1:00 PM
Public Transit Cost per participant: $55 CAD (+6% GST)
Explore Toronto on one of North America’s finest transportation Toronto is one of the most culturally diverse cities in the world.
systems—the Toronto Transit Commission (TTC)—as easy-to- Five ethnic communities (Chinese, Greek, Portuguese, Italian,
navigate subways, buses, and streetcars make getting around the Indian) all have cultural hubs spread throughout the downtown
city a snap. When using the TTC, a single fare will take you core. Toronto provides an ethnic flavor and variety that is simply
anywhere in the city on a one-way trip. You can freely transfer unmatched anywhere. In this tour, we explore three of the most
between subway, streetcar, and bus. popular communities: Chinatown on Spadina Street (including
Kensington Market), Greek Town on the Danforth, and Little
Driving Around Town Italy along College Street West. Next, we will travel to the CN
Toronto’s streets follow a basic grid pattern and are easy to navigate. Tower—the world’s tallest freestanding structure! We will take a
The city’s “rush hour” is more than an hour long—count on 58-second ride in a glass-faced elevator up the tower that will
heavy traffic from 7:00 – 9:00 AM and again from 4:00 – 6:00 PM. take you to the first of two lookout levels. Guests can also visit
the Observation Deck for spectacular views of the city, and, for a
unique view, guests can visit the Glass Floor, a mere 113 stories
(342 meters) above the streets below.
TRAVEL INFORMATION
Toronto Tours Continued walk through one of Toronto’s finest restored historic gardens that
Attendee
RESOURCES
Registration, Hotel, Travel
Itinerary Planner To register, complete the registration and consent form on page
(Supported by Merck & Co., Inc.) 48 or register online at www.kiddiecorp.com/endokids.htm.
The Endocrine Society’s Abstracts2ViewTM online Itinerary KiddieCorp must receive both the Childcare Registration Form
Planner will help you maximize your time at ENDO 07. The and full payment to hold reservations. The advance registration
itinerary planner will be available in April. deadline is May 11. Register early, as on-site registrations are not
guaranteed. Space is limited on a first-come, first-served basis.
• Search the abstract database by author, topic, or date.
For more information, contact KiddieCorp at 858.455.1718 or
• Decide what sessions you want to attend.
endokids@kiddiecorp.com.
• Create your personal ENDO 07 calendar.
• Add sessions quickly and easily to your calendar.
• Save your calendar and make updates regularly.
EXHIBIT HALL
The ENDO 07 Exhibit Hall will be open Saturday, June 2 –
Exhibit Sales
Monday, June 4, 10:30 AM – 4:00 PM.
For more information on exhibiting at ENDO 07, contact
Exhibit Planner Darrin Scherago or Steve Hamburger using one of the
The exhibit planner is a Web-based, searchable system you can following methods:
use to build an itinerary of exhibits you would like to visit. The
planner will be available in April. Mail: Scherago International
• Search exhibitors by product category, city, state, or company 525 Washington Blvd, Ste. 3310
• Find an exhibitor’s exact location in the Exhibit Hall Jersey City, NJ 07310
• Create a personalized planner to take to the Exhibit Hall
• Click through to exhibitor Web sites for more information Phone: 201.653.4777
• Email exhibitors directly
Web: www.scherago.com/endo
Research Park
Research Park is a special section in the Exhibit Hall to make it
easy for researchers to find high-interest products and services.
This special section features a collection of 40+ research-based
exhibitors.
Communications Central
(Supported by Genentech, Inc.)
Located throughout the convention center, attendees will find
computer terminals for internet accessibility. Access to these
computers will be available only during official Exhibit Hall
hours. You must use the terminals provided; there will be no
facilities for connecting your personal laptop in this area.
Poster Sessions
ENDO 07 will feature poster sessions on all four days of the
meeting. Saturday – Monday, you will find a new set of posters
interspersed throughout the Exhibit Hall, representing the most
current scientific information in the field of endocrinology.
Tuesday’s poster presentations will be in Hall C. Presenters will be
available for two hours each day at 11:00 AM and 2:30 PM.
Relaxation Station
Stop by the relaxation station for a 10-minute massage. The
relaxation station will be centrally located on the exhibit floor
and is open to all meeting attendees at no cost.
Book Store
The Endocrine Society’s Book Store will feature stylish
“endocrine” apparel for all ages, toys for your little ones, gifts for
friends and family, and even a little something for your pet.
EXHIBIT HALL
2 007 Exhibitors
Annual Meeting
CONTRIBUTORS
Annual Meeting Steering Committee
William F Young, Jr, MSc, MD, Chair Janet E Hall, MS, MD Renato Pasquali, MD
Mayo Clin Massachusetts Gen Hosp Univ Alma Mater (Italy)
Andrea C Gore, PhD, Basic Science Chair Marja M Hurley, MD Merrily F Poth, MD
Univ of Texas-Austin Univ of Connecticut Hlth Ctr Uniformed Svcs Univ of Hlth Scis
Peter J Trainer, MD, FRCP, Clinical Science Jens Jorgensen, MD, PhD Gail P Risbridger, PhD
& Practice Chair Aarhus Kommunehosp (Denmark) Monash Med Ctr (Australia)
Christie Hospital (UK)
W Lee Kraus, PhD Diane M Robins, PhD
Joseph T Bass, MD, PhD Cornell Univ Univ of Michigan Med Sch
Northwestern Univ
Benjamin Zev Leder, MD Delores M Shoback, MD
Daniel D Bikle, MD, PhD Massachusetts Gen Hosp Univ of California-San Francisco/
Univ of California-San Francisco/ VA Med Ctr
VA Med Ctr Ellis R Levin, MD
Long Beach VA Med Ctr Robert C Smallridge, MD
Louise M Bilezikjian, PhD Mayo Clin-Jacksonville
Salk Inst Jon E Levine, PhD
Northwestern Univ Doris A Stoffers, MD, PhD
Molly C Carr, MD Univ of Pennsylvania Sch of Med
Northwestern Univ Peter E Lobie, MD, PhD
Univ of Auckland (New Zealand) Larry J Suva, PhD
David R Clemmons, MD Univ of Arkansas for Med Sci
Univ of North Carolina Christos Mantzoros, MD
Beth Israel Deaconess Med Ctr Theo J Visser, PhD
John M Connell, MD, FRCP Erasmus Univ Med Ctr (Netherlands)
Univ of Glasgow (Scotland) Berenice B Mendonca, MD
Univ Sao Paulo Fac Med (Brazil) Wilmar Wiersinga, MD, PhD
Denise R Cooper, MS, PhD Univ of Amsterdam
JA Haley VA Hospital Walter L Miller, MD
Univ of California-San Francisco Robert S Zimmerman, MD
Samuel E Dagogo-Jack, MD, FRCP Cleveland Clin
Univ of Tennessee-Memphis Jeffrey N Miner, PhD
Ligand Pharmaceuticals
Kevin L Grove, PhD
Oregon Natl Primate Res Ctr Charles V Mobbs, PhD
Mt Sinai Sch of Med
Abbott Diagnostics
Abbott Laboratories
Abbott Renal
Altus Pharmaceuticals
Amgen
Astellas Pharma US, Inc.
AstraZeneca
Berlex Laboratories
Eli Lilly & Company
GATE Pharmaceuticals
Genentech, Inc.
Genzyme Corporation
GlaxoSmithKline Pharmaceuticals, Inc.
Indevus Pharmaceuticals, Inc.
Medtronic Minimed, Inc.
Merck & Co., Inc.
Novartis Pharmaceuticals
Novo Nordisk Inc.
Otsuka America Pharmaceutical, Inc.
Pfizer, Inc.
Quest Diagnostics
Sanofi-Aventis
Solvay
Takeda Pharmaceuticals
North America, Inc.
Tercica, Inc.
Contact
INFORMATION
The Endocrine Society Registration & Housing Travel
Mail: 8401 Connecticut Ave., Suite 900 Mail: ENDO 2007 Registrar Email: reservations@atcmeetings.com
Chevy Chase, MD 20815 c/o Laser Registration
1200 G Street, NW, Suite 800 Fax: 858.362.3153
Phone: 888.363.6274 or 301.941.0200 Washington, DC 20005-3967
(main) Web: www.atcmeetings.com/endocrine
888.363.6762 or 301.941.0210 Phone: 888.695.5481 (toll free)
(Society Services) 202.347.6659 (main)
301.941.0220 (Meetings Services)
301.941.0231 (Membership) Fax: 888.695.5498 (domestic)
514.228.3202 (international)
Fax: 301.941.0259 (main)
301.941.0257 (Society Services) Email: ENDO@Laser-Registration.com
301.941.0259 (Membership)
Web: https://www.one-stop-
Web: www.endo-society.org (main) registration.com/endo
www.endo-society.org/endo
(ENDO 07)
EMPLOYERS
• Postjobs in the online Employment
Opportunities Database
• Receive CV’s from all registered candidates
Participate. CANDIDATES
• Post your CV in the online CV Database
• Receive job descriptions from all registered
employers
• Participate in interviews on-site
I n t ro d u c i n g t h e E N D O 0 7 S e s s i o n L i b ra r y .
EARLY REGISTRATION DEADLINE: APRIL 7, 2007 • ADVANCE REGISTRATION DEADLINE: MAY 11, 2007
A. REGISTRATION INFORMATION (PLEASE PRINT ALL INFORMATION)
Prefix
° Dr. ° Mr. ° Ms. ° Prof.
LAST NAME FIRST NAME MIDDLE INITIAL
Check applicable degrees:
° MD ° PhD ° MD, PhD
° RN Ê° DO ÊÊ° RPh COMPANY/INSTITUTION
° Other:_____________
Which of the following best
describes your primary & DEPARTMENT/DIVISION
secondary professional role?
(“1” for primary; “2” for secondary)
_____ Administrator MAILING ADDRESS STREET
-
_____ Basic Researcher
_____ Clinical Researcher
_____ Clinical Practitioner CITY STATE COUNTRY ZIP/POSTAL CODE
_____ Fellow, Clinical
_____ Fellow, Postdoc/Research
_____ Industry/Corporate TELEPHONE (DAY): COUNTRY CODE/CITY CODE/NUMBER FAX: COUNTRY CODE/CITY CODE/NUMBER
_____ Nurse/Healthcare
_____ Retired
_____ Student E-MAIL
_____ Teacher/Educator
ALL INFORMATION IN SECTION A MUST BE COMPLETED IN ORDER TO REGISTER. IF INFORMATION IS NOT APPLICABLE PLEASE INDICATE N/A IN THE SPACE PROVIDED.
_____ Other
GUEST LAST NAME GUEST FIRST NAME DAY TELEPHONE EVENING TELEPHONE
TOTAL SECTION B: $ ________
C. EVENT & WORKSHOP FEES I. CANCELLATION POLICY
1 Thyroid Sonography Hands-on Wkshop, Fri June 1 (limited to first 65 registrants) Cancellations must be made in writing by May 11, 2007. See
°ÊÊMember and ENDO attendee $350 ________ registration instruction pages for the complete cancellation policy.
°ÊÊNon-Member and ENDO attendee Ê Ê $400 ________ J. METHOD OF PAYMENT
°ÊÊFellow/Student and ENDO attendee $250 ________
2 Women in Endocrinology Dinner, Sat June 2 Full payment must accompany your registration form. Enclose your check
°ÊÊAll attendees $65 ________ (payable to The Endocrine Society in U.S. funds only), or complete the credit
3 Cardiovascular Endocrinology Dinner, Mon June 4 card information below. American Express and purchase orders are not
°ÊÊAll attendees $50 ________ accepted as payment for registration fees.
20ÊABIM Self-Evaluation Process, Fri June 1 ° Check ° Money Order ° VISA ° MasterCard
(Add’l fee req’d. Details at http://www.endo-society.org/endo)
°ÊÊMember $100 ________
° Non-Member $150 ________ CARD NUMBER EXPIRATION DATE
°ÊÊIn Training Member/Non-Member $50 ________
TOTAL SECTION C: $ ________ NAME OF CARDHOLDER (PLEASE PRINT)
D. OPTIONAL FEES
"Grab-n-Go” Lunches - $12 per day ________ BILLING ADDRESS
4 °ÊÊSAT 5 °ÊSUN 6 °ÊMON 7 °ÊTUES (SELECT DAYS)
ENDO 07 Session Library – ENDO Attendees only (Select both format and program) SIGNATURE
FORMAT: °ÊÊ12 Month Online Access or °ÊDVD-ROM YOUR SIGNATURE AUTHORIZES YOUR CREDIT CARD TO BE CHARGED FOR THE TOTAL PAYMENT ABOVE.
THE ENDOCRINE SOCIETY RESERVES THE RIGHT TO CHARGE THE CORRECT AMOUNT IF DIFFERENT FROM
Complete Clinical Basic THE TOTAL PAYMENT LISTED ABOVE.
MEMBER Program Program Program
Professional °Ê$110 °Ê$70 °Ê$70 ________
In Training/Emeritus °Ê$80 °Ê$50 °Ê$50 ________
NON-MEMBER OR FAX REGISTRATION FORM
Professional °Ê$150 °Ê$100 °Ê$100 ________ with credit card information no later than May 11, 2007 to
In Training °Ê$120 °Ê$70 °Ê$70 ________ 888.695.5498 or Int'l fax 514.228.3202.
TOTAL SECTION D: $ ________ If faxing, do not mail or you will be double-charged.
E.E.PAYMENT
PAYMENTDUE
DUE TOTAL (B + C + D): $ ________ OR MAIL REGISTRATION FORM
with full payment no later than May 11, 2007 to:
ENDO 2007 Registrar
c/o Laser Registration
REGISTER ONLINE with credit card information at
1200 G Street, NW, Suite 800
www.one-stop-registration.com/endo/
Washington, DC 20005-3967
45
Endo2007_KCC TEXT 2/19/07 12:28 PM Page 46
CEU 2007
Leading edge updates, advancements and
review on important topics in Endocrinology.
Thyroid / Pituitary / Bone & Mineral / Reproduction
Diabetes / Lipids & Cardiovascular / Adrenal & Hypertension
Additional programs:
Board Review
SEPTEMBER 25-26
Thyroid Sonography
Hands-On Workshop
SEPTEMBER 30
REGISTER EARLY
for a chance to win one night free.
To be entered to win the free night’s stay, register before August 17, 2007.
Visit www.endo-society.org/education/events/ceu for information and registration.
Endo2007_KCC TEXT 2/19/07 12:28 PM Page 47
%.$/ (/53).'